| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | A01-01_57_1_1697 | Phenotype:Parental | AU |
| Reversed phase POSITIVE ION MODE | A01-02_57_1_1698 | Phenotype:Parental | AU |
| Reversed phase POSITIVE ION MODE | A02-01_58_1_1699 | Phenotype:Parental | AU |
| Reversed phase POSITIVE ION MODE | A02-02_58_1_1700 | Phenotype:Parental | AU |
| Reversed phase POSITIVE ION MODE | A03-01_59_1_1701 | Phenotype:Parental | AU |
| Reversed phase POSITIVE ION MODE | A03-02_59_1_1702 | Phenotype:Parental | AU |
| Reversed phase POSITIVE ION MODE | B01-01_60_1_1703 | Phenotype:Resistant | AU |
| Reversed phase POSITIVE ION MODE | B01-02_60_1_1704 | Phenotype:Resistant | AU |
| Reversed phase POSITIVE ION MODE | B02-01_61_1_1705 | Phenotype:Resistant | AU |
| Reversed phase POSITIVE ION MODE | B02-02_61_1_1706 | Phenotype:Resistant | AU |
| Reversed phase POSITIVE ION MODE | B03-01_62_1_1707 | Phenotype:Resistant | AU |
| Reversed phase POSITIVE ION MODE | B03-02_62_1_1708 | Phenotype:Resistant | AU |
Return to study ST002273 main page
Download data matrix(Multi-Omics analysis revealed a significant alteration of critical metabolic pathways due to sorafenib-resistance in Hep3B cell lines Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|